Harvard Bioscience Company Profile (NASDAQ:HBIO)

About Harvard Bioscience

Harvard Bioscience logoHarvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company's products consist of instruments, consumables and systems that are made up of various individual products.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: HBIO
  • CUSIP: 41690610
Key Metrics:
  • Previous Close: $2.90
  • 50 Day Moving Average: $3.01
  • 200 Day Moving Average: $2.70
  • 52-Week Range: $34,374,000.00 - $2.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 15.26
  • P/E Growth: 1.81
  • Market Cap: $99.68M
  • Outstanding Shares: 34,374,000
  • Beta: 1.11
Profitability:
  • Net Margins: -18.90%
  • Return on Equity: 3.73%
  • Return on Assets: 2.48%
Debt:
  • Debt-to-Equity Ratio: 0.17%
  • Current Ratio: 3.20%
  • Quick Ratio: 1.73%
Additional Links:
Companies Related to Harvard Bioscience:

Analyst Ratings

Consensus Ratings for Harvard Bioscience (NASDAQ:HBIO) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.75 (98.28% upside)

Analysts' Ratings History for Harvard Bioscience (NASDAQ:HBIO)
Show:
DateFirmActionRatingPrice TargetDetails
11/21/2016Benchmark Co.Set Price TargetBuy$6.00View Rating Details
11/17/2016Singular ResearchInitiated CoverageBuy$5.50View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Harvard Bioscience (NASDAQ:HBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017        
7/28/2016Q2$0.03$0.03$26.60 million$26.10 millionViewListenView Earnings Details
5/12/2016Q1$0.02$0.05$26.00 million$27.00 millionViewListenView Earnings Details
4/29/2016Q4$0.03$0.03ViewN/AView Earnings Details
10/29/2015Q315$0.05$0.03$27.01 million$25.70 millionViewListenView Earnings Details
7/30/2015Q215$0.04$0.05$26.60 million$28.80 millionViewListenView Earnings Details
4/30/2015Q414$0.05$0.01$27.15 million$25.80 millionViewListenView Earnings Details
2/26/2015Q314$0.09$0.10$29.30 million$30.40 millionViewN/AView Earnings Details
10/30/2014Q214$0.06$0.06$25.46 million$25.40 millionViewN/AView Earnings Details
7/31/2014Q2$0.05$0.05ViewN/AView Earnings Details
5/1/2014Q114$0.03$0.05$26.10 million$25.90 millionViewN/AView Earnings Details
2/27/2014Q413($0.02)$0.05$28.20 million$27.90 millionViewN/AView Earnings Details
10/31/2013Q313$0.01$0.05$26.10 million$25.10 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.08$28.30 million$26.10 millionViewN/AView Earnings Details
11/1/2012Q312$0.08$26.40 million$26.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Harvard Bioscience (NASDAQ:HBIO)
Current Year EPS Consensus Estimate: $0.16 EPS
Next Year EPS Consensus Estimate: $0.19 EPS

Dividends

Dividend History for Harvard Bioscience (NASDAQ:HBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Harvard Bioscience (NASDAQ:HBIO)
Insider Ownership Percentage: 8.80%
Institutional Ownership Percentage: 63.61%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/7/2017David GreenDirectorSell3,239$3.25$10,526.75View SEC Filing  
2/6/2017David GreenDirectorSell1,288$3.25$4,186.00View SEC Filing  
12/6/2016Earl R. LewisDirectorSell23,088$2.42$55,872.96View SEC Filing  
11/3/2016Jeffrey DucheminCEOBuy15,000$2.42$36,300.00View SEC Filing  
11/3/2016Robert E. GagnonCFOBuy25,000$2.34$58,500.00View SEC Filing  
12/10/2015Jeffrey DucheminCEOBuy10,000$3.37$33,700.00View SEC Filing  
12/3/2015George UvegesDirectorBuy3,000$3.32$9,960.00View SEC Filing  
11/9/2015Robert E GagnonCFOBuy3,000$3.08$9,240.00View SEC Filing  
9/2/2015Jeffrey DucheminCEOBuy2,000$4.41$8,820.00View SEC Filing  
9/1/2015John F KennedyDirectorBuy2,000$4.33$8,660.00View SEC Filing  
7/17/2015David GreenDirectorSell17,103$5.26$89,961.78View SEC Filing  
7/14/2015David GreenDirectorSell51,597$5.28$272,432.16View SEC Filing  
4/23/2015David GreenDirectorSell118,500$6.03$714,555.00View SEC Filing  
4/22/2015David GreenDirectorSell123,997$6.23$772,501.31View SEC Filing  
4/17/2015David GreenDirectorSell42,503$6.55$278,394.65View SEC Filing  
4/14/2015David GreenDirectorSell80,168$6.61$529,910.48View SEC Filing  
2/9/2015David GreenDirectorSell48,712$5.25$255,738.00View SEC Filing  
12/30/2014David GreenDirectorSell16,173$5.25$84,908.25View SEC Filing  
12/29/2014David GreenDirectorSell100,167$5.25$525,876.75View SEC Filing  
12/22/2014David GreenDirectorSell80,202$5.02$402,614.04View SEC Filing  
11/19/2014David GreenDirectorSell10,000$4.95$49,500.00View SEC Filing  
10/31/2014David GreenDirectorSell117,654$4.97$584,740.38View SEC Filing  
6/16/2014Robert E GagnonCFOBuy5,000$3.86$19,300.00View SEC Filing  
5/29/2014Neal J HarteDirectorSell12,317$3.82$47,050.94View SEC Filing  
4/9/2014David GreenDirectorSell27,540$4.47$123,103.80View SEC Filing  
4/8/2014David GreenDirectorSell66,090$4.48$296,083.20View SEC Filing  
4/3/2014David GreenDirectorSell63,501$4.63$294,009.63View SEC Filing  
8/27/2013Chane GrazianoMajor ShareholderBuy60,000$5.00$300,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Harvard Bioscience (NASDAQ:HBIO)
DateHeadline
finance.yahoo.com logoHarvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET (NASDAQ:HBIO)
finance.yahoo.com - February 23 at 5:37 PM
capitalcube.com logoETFs with exposure to Harvard Bioscience, Inc. : January 12, 2017 (NASDAQ:HBIO)
www.capitalcube.com - January 12 at 6:04 PM
seekingalpha.com logoHarvard Bioscience, Inc. (HBIO) Presents At Singular Research "Uncovered Values & Special Situation Web Call" (NASDAQ:HBIO)
seekingalpha.com - December 20 at 10:54 AM
thestreet.com logoHarvard Bioscience an 'Asymmetrical Long Shot' (NASDAQ:HBIO)
realmoney.thestreet.com - December 19 at 11:50 AM
capitalcube.com logoETFs with exposure to Harvard Bioscience, Inc. : December 16, 2016 (NASDAQ:HBIO)
www.capitalcube.com - December 16 at 6:09 PM
News IconHarvard Bioscience, Inc. (HBIO): Are Hedge Funds Right About This Stock? (NASDAQ:HBIO)
feedproxy.google.com - December 16 at 9:29 AM
News IconHarvard Bioscience, Inc. HBIO Financial and Strategic SWOT Analysis Review Prices from USD $125 (NASDAQ:HBIO)
www.bioportfolio.com - November 23 at 5:24 PM
News IconHarvard Bioscience, Inc. HBIO Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:HBIO)
www.bioportfolio.com - November 18 at 4:52 PM
finance.yahoo.com logoCoverage initiated on Harvard Biosci by Singular Research (NASDAQ:HBIO)
finance.yahoo.com - November 17 at 4:54 PM
News IconHarvard Bioscience, Inc. HBIO Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:HBIO)
www.bioportfolio.com - November 16 at 8:49 AM
finance.yahoo.com logoHARVARD BIOSCIENCE INC Financials (NASDAQ:HBIO)
finance.yahoo.com - November 10 at 4:46 PM
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : November 2, 2016 (NASDAQ:HBIO)
www.capitalcube.com - November 2 at 5:36 PM
capitalcube.com logoHarvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016 (NASDAQ:HBIO)
www.capitalcube.com - October 31 at 5:30 PM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 27-Oct-16 8:30pm GMT (NASDAQ:HBIO)
finance.yahoo.com - October 29 at 8:17 AM
publicnow.com logoHarvard Bioscience Reports Third Quarter 2016 Financial Results (NASDAQ:HBIO)
www.publicnow.com - October 27 at 5:26 PM
biz.yahoo.com logoHarvard Bioscience Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:HBIO)
biz.yahoo.com - October 27 at 5:26 PM
biz.yahoo.com logoQ3 2016 Harvard Bioscience Inc Earnings Release - After Market Close (NASDAQ:HBIO)
biz.yahoo.com - October 27 at 10:07 AM
4-traders.com logoHARVARD BIOSCIENCE SCHEDULES THIRD QUARTER 2016 CONFERENCE CALL FOR OCTOBER 27 AT 4 : 30 pm et (NASDAQ:HBIO)
www.4-traders.com - October 13 at 5:24 PM
publicnow.com logoHarvard Bioscience Schedules Third Quarter 2016 Conference Call for October 27 at 4:30 PM ET (NASDAQ:HBIO)
www.publicnow.com - October 13 at 5:24 PM
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : September 27, 2016 (NASDAQ:HBIO)
www.capitalcube.com - September 27 at 5:21 PM
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : September 9, 2016 (NASDAQ:HBIO)
www.capitalcube.com - September 9 at 5:09 PM
finance.yahoo.com logoHarvard Bioscience (HBIO): Moving Average Crossover Alert (NASDAQ:HBIO)
finance.yahoo.com - August 29 at 5:16 PM
bizjournals.com logoEXCLUSIVE: UW president lays out vision for Global Innovation Exchange (NASDAQ:HBIO)
www.bizjournals.com - August 17 at 5:36 PM
capitalcube.com logoHarvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:HBIO)
www.capitalcube.com - August 11 at 5:38 PM
sg.finance.yahoo.com logoHarvard Bioscience reports 2Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - July 28 at 10:42 AM
finance.yahoo.com logo7:30 am Harvard Bioscience reports Q2; guides FY16 (NASDAQ:HBIO)
finance.yahoo.com - July 28 at 7:30 AM
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : July 21, 2016 (NASDAQ:HBIO)
www.capitalcube.com - July 21 at 2:06 PM
4-traders.com logoHARVARD BIOSCIENCE SCHEDULES SECOND QUARTER 2016 CONFERENCE CALL FOR JULY 28 AT 8 : 30 am et (NASDAQ:HBIO)
www.4-traders.com - July 18 at 5:34 PM
finance.yahoo.com logoHarvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET (NASDAQ:HBIO)
finance.yahoo.com - July 18 at 4:30 PM
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : July 1, 2016 (NASDAQ:HBIO)
www.capitalcube.com - July 1 at 6:17 PM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:HBIO)
biz.yahoo.com - June 27 at 4:16 PM
publicnow.com logoHarvard Bioscience to Attend The Benchmark Company, LLC One-on-One Conference in Milwaukee, Wisconsin on June 2, 2016 (NASDAQ:HBIO)
www.publicnow.com - May 31 at 6:42 AM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi (NASDAQ:HBIO)
biz.yahoo.com - May 27 at 4:11 PM
capitalcube.com logoHarvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:HBIO)
www.capitalcube.com - May 13 at 12:16 PM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 12-May-16 12:30pm GMT (NASDAQ:HBIO)
finance.yahoo.com - May 12 at 10:50 AM
biz.yahoo.com logoQ4 2015 and Q1 2016 Harvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 8:30 AM
biz.yahoo.com logoQ1 2016 Harvard Bioscience Inc Earnings Release - Before Market Open (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 7:07 AM
publicnow.com logoHarvard Bioscience Reports First Quarter 2016 Financial Results (NASDAQ:HBIO)
www.publicnow.com - May 12 at 6:27 AM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 6:24 AM
sg.finance.yahoo.com logoHarvard Bioscience reports 1Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - May 12 at 6:15 AM
publicnow.com logoHarvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements (NASDAQ:HBIO)
www.publicnow.com - May 4 at 4:20 PM
finance.yahoo.com logoHarvard Bioscience Regains Compliance with NASDAQ’s Continued Listing Requirements (NASDAQ:HBIO)
finance.yahoo.com - May 4 at 4:15 PM
thestreet.com logoHarvard Bioscience Reports Fourth Quarter And Year-End 2015 Results, Preliminary First Quarter 2016 Revenues And 2016 Financial Guidance (NASDAQ:HBIO)
www.thestreet.com - April 29 at 5:42 PM
sg.finance.yahoo.com logoHarvard Bioscience reports 4Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - April 29 at 5:07 PM
seekingalpha.com logoHarvard Bioscience to delay 10-K filing, reports Preliminary Q4 revenue (NASDAQ:HBIO)
seekingalpha.com - March 28 at 6:55 PM
News IconCould Harvard Bioscience, Inc. Rise Even More? The Stock Had Another Big Increase Today - RiversideGazette.com (NASDAQ:HBIO)
www.riversidegazette.com - February 26 at 1:00 PM
News IconEarnings Per Share Preview for Harvard Bioscience, Inc. (HBIO) - RiversideGazette.com (NASDAQ:HBIO)
www.riversidegazette.com - February 26 at 1:00 PM
News IconWhy Heartland Advisors Inc Reported Big Harvard Bioscience Inc Position? - fdanewsalert.com (NASDAQ:HBIO)
www.fdanewsalert.com - February 5 at 2:42 PM
biz.yahoo.com logoQ3 2015 Harvard Bioscience Inc Earnings Release - Before Market Open (NASDAQ:HBIO)
biz.yahoo.com - October 29 at 7:07 AM
sg.finance.yahoo.com logoHarvard Bioscience reports 3Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - October 29 at 7:03 AM

Social

What is Harvard Bioscience's stock symbol?

Harvard Bioscience trades on the NASDAQ under the ticker symbol "HBIO."

Where is Harvard Bioscience's stock going? Where will Harvard Bioscience's stock price be in 2017?

2 brokerages have issued 12 month price objectives for Harvard Bioscience's shares. Their forecasts range from $5.50 to $6.00. On average, they expect Harvard Bioscience's share price to reach $5.75 in the next twelve months.

When will Harvard Bioscience announce their earnings?

Harvard Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, April, 27th 2017.

Who owns Harvard Bioscience stock?

Harvard Bioscience's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include First Light Asset Management LLC (7.98%), Dimensional Fund Advisors LP (4.69%), Royce & Associates LP (4.40%), Glacier Peak Capital LLC (3.36%), Jupiter Asset Management Ltd. (2.48%) and Renaissance Technologies LLC (1.54%). Company insiders that own Harvard Bioscience stock include David Green, Earl R Lewis, George Uveges, Jeffrey Duchemin, John F Kennedy and Robert E Gagnon.

Who sold Harvard Bioscience stock? Who is selling Harvard Bioscience stock?

Harvard Bioscience's stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, First Light Asset Management LLC, GSA Capital Partners LLP, Bard Associates Inc. and Jupiter Asset Management Ltd.. Company insiders that have sold Harvard Bioscience stock in the last year include David Green and Earl R Lewis.

Who bought Harvard Bioscience stock? Who is buying Harvard Bioscience stock?

Harvard Bioscience's stock was purchased by a variety of institutional investors in the last quarter, including Glacier Peak Capital LLC, GRT Capital Partners L.L.C., Renaissance Technologies LLC and Dimensional Fund Advisors LP. Company insiders that have bought Harvard Bioscience stock in the last two years include George Uveges, Jeffrey Duchemin, John F Kennedy and Robert E Gagnon.

How do I buy Harvard Bioscience stock?

Shares of Harvard Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Harvard Bioscience stock cost?

One share of Harvard Bioscience stock can currently be purchased for approximately $2.90.

Harvard Bioscience (NASDAQ:HBIO) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Harvard Bioscience (NASDAQ:HBIO)

Earnings History Chart

Earnings by Quarter for Harvard Bioscience (NASDAQ:HBIO)

Dividend History Chart

Dividend Payments by Quarter for Harvard Bioscience (NASDAQ:HBIO)

Last Updated on 2/27/2017 by MarketBeat.com Staff